SEC Probe Nets Another Suspect In Connetics Case

Law360, New York (May 25, 2006, 12:00 AM EDT) -- Hoping to add another defendant to the roster, The U.S. Securities & Exchange Commission is seeking to amend its insider trading complaint against a Connetics Corp. executive to include a former neighbor after both allegedly traded on non-public information related to the company’s acne drug, Velac Gel.

On Wednesday, the SEC filed a motion to add Victor Zak as a defendant in the lawsuit, two months after regulators charged Alexander Yaroshinsky, Connetics' vice president of biostatistics and clinical operations, with engaging in improper trading.

The two...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.